iPSCs: Recent Clinical Insights & Progress
IRCIP PARIS ’26 : Where iPSC Research Meets Clinical Reality
12–13 November 2026 · Paris, France
Join leading scientists, clinicians and biotechnology innovators for two days dedicated to the latest advances in induced pluripotent stem cell research and its translation into clinical applications.
Discover emerging iPSC-based therapies and technologies across:
- Cancer immunotherapy and disease modelling
- Cardiology and regenerative medicine
- Neurology and ophthalmology
- Diabetes and sensory disorders
- Cell manufacturing, quality control and cGMP production
- Autologous and allogeneic therapeutic strategies
The programme brings together internationally recognised speakers from Europe, Asia and North America, with keynote lectures, scientific presentations, panel discussions, posters and networking opportunities.
Why attend?
Access clinical insight
Learn how iPSC-derived products are progressing from experimental models towards clinical trials and therapeutic use.
Meet the field’s leading experts
Connect with researchers, clinicians, manufacturers, biotechnology companies and potential collaborators.
Explore emerging technologies
Examine advances in reprogramming, differentiation, organoids, immune-cell therapies, genomic quality control and scalable manufacturing.
Build new collaborations
Present your work, exchange ideas and identify opportunities for scientific and industrial partnerships.
Be part of the next stage of iPSC medicine
Whether you work in academic research, clinical development, biotechnology, manufacturing or investment, this meeting offers a focused view of where the field is heading—and who is driving it forward.
Places are limited. Register now and join the international iPSC community in Paris.
